000 | 01325 a2200397 4500 | ||
---|---|---|---|
005 | 20250511182129.0 | ||
264 | 0 | _c19920916 | |
008 | 199209s 0 0 eng d | ||
022 | _a0301-0147 | ||
024 | 7 |
_a10.1159/000216296 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMeuleman, D G | |
245 | 0 | 0 |
_aOrgaran (Org 10172): its pharmacological profile in experimental models. _h[electronic resource] |
260 |
_bHaemostasis _c1992 |
||
300 |
_a58-65 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCarbohydrate Sequence |
650 | 0 | 4 | _aChondroitin Sulfates |
650 | 0 | 4 | _aDermatan Sulfate |
650 | 0 | 4 | _aFactor Xa Inhibitors |
650 | 0 | 4 |
_aFibrinolytic Agents _xpharmacology |
650 | 0 | 4 |
_aGlycosaminoglycans _xpharmacology |
650 | 0 | 4 |
_aHemorrhage _xchemically induced |
650 | 0 | 4 |
_aHeparinoids _xpharmacology |
650 | 0 | 4 | _aHeparitin Sulfate |
650 | 0 | 4 | _aMolecular Sequence Data |
650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
650 | 0 | 4 | _aRabbits |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aThrombin _xantagonists & inhibitors |
650 | 0 | 4 | _aThrombolytic Therapy |
650 | 0 | 4 |
_aThrombosis _xdrug therapy |
773 | 0 |
_tHaemostasis _gvol. 22 _gno. 2 _gp. 58-65 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000216296 _zAvailable from publisher's website |
999 |
_c1386459 _d1386459 |